Streetbeat News

Analyst Ratings

META

Pivotal Research has initiated coverage on Meta Platforms with a Buy rating and set a price target of $780.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:58 am

GANX

HC Wainwright & Co. has reiterated its Buy rating on Gain Therapeutics (NASDAQ:GANX) and maintained a price target of $8, indicating confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:57 am

GOOG

Pivotal Research has initiated coverage on Alphabet with a Buy rating and set a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:55 am

XENE

HC Wainwright & Co. has initiated coverage on Xenon Pharmaceuticals with a Buy rating and set a price target of $53.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:51 am

PRTA

HC Wainwright & Co. has reiterated its Buy rating for Prothena Corp, maintaining a price target of $84.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:42 am

TTD

Needham analyst Laura Martin maintains a Buy rating on Trade Desk (NASDAQ:TTD) and raises the price target from $115 to $125.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:34 am

ACMR

Needham analyst Charles Shi has reiterated a Buy rating on ACM Research (NASDAQ:ACMR) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:28 am

NMRA

HC Wainwright & Co. has initiated coverage on Neumora Therapeutics with a Buy rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:26 am

AEON

HC Wainwright & Co. has reiterated its Buy rating on AEON Biopharma, maintaining a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:20 am

RLYB

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Rallybio (NASDAQ:RLYB) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:13 am